Insider Transactions in Q2 2023 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
990
+2.87%
|
-
|
|
Jun 20
2023
|
David E. Wheadon |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 20
2023
|
Atul Pande |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 20
2023
|
Christopher J Coughlin |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 20
2023
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 20
2023
|
Laurie J Olson |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 20
2023
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
-
|
|
Jun 14
2023
|
James Healy |
BUY
Other acquisition or disposition
|
Indirect |
8,025
+50.0%
|
-
|
|
Jun 14
2023
|
James Healy |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-22.57%
|
-
|
|
May 23
2023
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,000
-4.19%
|
$2,007,000
$223.67 P/Share
|
|
May 23
2023
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+18.56%
|
$81,000
$9.2 P/Share
|
|
Apr 20
2023
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
15,000
-38.07%
|
$3,000,000
$200.13 P/Share
|
|
Apr 20
2023
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+17.75%
|
$76,500
$9.2 P/Share
|
|
Apr 18
2023
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
30,000
-49.26%
|
$6,000,000
$200.16 P/Share
|
|
Apr 18
2023
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+33.0%
|
$270,000
$9.2 P/Share
|
|
Apr 10
2023
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-17.45%
|
$880,000
$176.88 P/Share
|
|
Apr 10
2023
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.86%
|
$45,000
$9.2 P/Share
|
|
Apr 03
2023
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$181,000
$181.02 P/Share
|
|
Apr 03
2023
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|